STOCKHOLM, Oct. 25, 2013 /PRNewswire/ -- Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working member of its Board of Directors per the same date.
Niklas Savander has extensive experience from senior management positions both within Hewlett Packard and Nokia, most recently as a member of Nokia's Executive Management Team responsible for the Company's day-to-day operations. He is currently a Private Equity Adviser in Helsinki, Stockholm and London. Mr. Savander is married and has two children.
Laurent Leksell, Elekta's founder, former CEO and Chairman of the Board of Directors, commented: "We are very pleased to have been able to appoint such an experienced and capable executive as Niklas Savander. His deep understanding of complex global technology industries, as well as his experience from global markets, is uniquely suited to lead Elekta through our next phase of profitable growth."
Commenting on Tomas Puusepp, Laurent Leksell said: "Tomas Puusepp has done a more than outstanding job as CEO. Under his leadership, Elekta has become a full-service Radiation Therapy company with the ambition to become the market leader in the next couple of years. I am pleased that Tomas has decided to continue working for Elekta as full-time member of the Board of Directors."
Niklas Savander commented: "I feel honored. Elekta is a remarkable company: innovative, well-managed and fast-growing. I am excited about the opportunity, knowing what difference this company makes in the lives of people with cancer."
Mr. Savander will join Elekta on January 1st 2014 in order to prepare himself for his new role. He will start as Elekta's President and CEO effective May 1st 2014.
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31653561242, e-mail firstname.lastname@example.org
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: email@example.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 7:30 CET on October 25, 2013.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.